Viewing Study NCT00641056

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-02-10 @ 8:55 AM
Study NCT ID: NCT00641056
Status: COMPLETED
Last Update Posted: 2015-06-15
First Post: 2008-03-17
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None diabetes View
None exenatide View
None exenatide once weekly View
None metformin View
None sulfonylurea View
None insulin glargine View
None Amylin View
None Lilly View